CopyMark Law Group
4.9/5
Drawing for CLARIPURE

USPTO serial 79375157

CLARIPURE

Reviewed by CopyMark Law Group

Reg. 8299518Status 700Registered
Filing date
Status date
Registration date
Jun 16, 2026
Examiner
THOMAS, JULIE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CLARIPURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

H. David Starr

H. David Starr Muncy, Geissler, Olds & Lowe, P.C.125 S. Royal StreetAlexandria, VA 22314United States

Goods and services

ClassDescriptionStatusFirst use
009Laboratory equipment, apparatus and instruments, namely, fluid handling device used for disposable bioprocessing applications and parts and fittings therefor; dosing devices, namely, dispensers of preset portions of fluids, solid granules and powder for dosing purposes, all not for medical use; laboratory equipment and apparatus of plastic with clamp-style connectors, namely, sterile tubing  and sample bags, single-use bioprocessing containers, single-use bioprocessing bags, filters used as laboratory equipment for pharmaceutical, biopharmaceutical or biotechnological applications, all of the foregoing not for medical use; Sterile sampling plastic bags, for scientific and laboratory purposes; Scientific research specimen collection devices in the nature of plastic bags, tubings and hoses for the collection of a variety of liquids and biologicals; laboratory equipment, namely, single-use sterile sample bags, laboratory flasks, closures for laboratory bags and bottles and stoppers for laboratory bags and bottlesACTIVE—
010Single-use medical bags, sold empty, for the preparation, mixing, storage and transport of biological fluids and biopharmaceutical solutions; flexible plastic bags, sold empty, for the preparation, mixing, storage and transport of biological fluids and medical, pharmaceutical or biopharmaceutical liquids, all for medical purposes; bags for medical purposes, namely, plastic bags for transmitting medical specimens; bags for medical purposes, namely, bags for medical waste; medical tubes for biological fluids sampling and collection for medical purposes; medical tubing assemblies in the nature of flexible plastic and silicone tubing used for transport of biological materials for use in the pharmaceutical and medical industries; surgical apparatus and instruments; medical apparatus and instruments, namely, containers for medical waste; replacement and structural parts and fittings for surgical apparatus, surgical instruments, medical apparatus, medical instruments, medical diagnostic devicesACTIVE—
017Flexible tubes, not of metal; flexible hoses, not of metal; fittings, not of metal, for hoses and flexible tubes of plastic; all aforementioned goods used in the medical, biomedical, pharmaceutical and food and beverage industriesACTIVE—
042Scientific research relating to systems using single-use medical bags for the preparation, mixing, storage and transport of fluids and biopharmaceutical solutions; technological research services relating to design and development of systems using single- use medical bags for the preparation, mixing, storage and transport of fluids and biopharmaceutical solutions; new product development for others of systems using single-use medical bags for the preparation, mixing, storage and transport of fluids and biopharmaceutical solutionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 16, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 16, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 16, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 28, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 28, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 23, 2026GPNXNOTIFICATION PROCESSED BY IB—
Apr 22, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 8, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 8, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 27, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 18, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Mar 18, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 18, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 18, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 6, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 6, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 6, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 26, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 26, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 26, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 10, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 25, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 25, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 5, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 12, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 12, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 12, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2024RFNTREFUSAL PROCESSED BY IB—
Mar 4, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 4, 2024RFRRREFUSAL PROCESSED BY MPU—
Feb 10, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 9, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 25, 2024DOCKASSIGNED TO EXAMINER—
Aug 1, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 28, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 27, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance